Items tagged with Diagnostics
Tuberculosis makes a comeback (post with simple image)
Yerevan, Armenia - In a barren hospital room, Arman lies on a messily made bed as a nurse administers one of two daily antibiotic injections into his forearm. The 35-year-old ex-soldier was admitted nearly 18-months ago, having suffered a relapse of the bacterial lung infection tuberculosis (TB).
Punked by pharma: Public funds for private products (post with simple image)
Tax dollars are making it easier for the drug and diagnostics industry to develop and market essential TB products. Is the public getting a fair return on its investment?
Drug shortages threaten US anti-TB efforts (post with simple image)
Mounting problems with accessing life-saving products to diagnose and treat TB threaten the progress made against this communicable disease.
Reduced treatment delays for people with drug-resistant TB and HIV co-infection through decentralised care and rapid Xpert MTB/RIF test (post with simple image)
Decentralisation of drug-resistant tuberculosis (DR-TB) management and use of the Xpert MTB/RIF test improves the time from clinic presentation to treatment from 50 days to 7 days in a population with a high burden of HIV and TB co-infection, according to a study from Khayelitsha, South Africa, presented at the 20th International AIDS Conference (AIDS 2014) on Monday.
New tuberculosis blood test in children is reliable and highly specific (post with simple image)
A newly developed test (TAM-TB assay) is the first reliable immunodiagnostic assay to detect active tuberculosis in children.
UNITAID: Tuberculosis diagnostics technology and market landscape – 3rd edition (post with simple image)
The report highlights current and emerging technologies from over 80 manufacturers and developers, including products which are smaller, simpler and easier to use in decentralized settings than the current tools used by the majority of high-burden TB countries.
Meeting report: High-priority target product profiles for new tuberculosis diagnostics (post with simple image)
Report of a consensus meeting convened by the Global TB Programme of the World Health Organization.
UNITAID’s EXPAND-TB and TBXpert MTB-RIF projects detect over a quarter of all MDR-TB cases (post with simple image)
Geneva, 22nd October 2014 – UNITAID welcomes new data in the World Health Organization’s new global report on tuberculosis (TB) which shows a 30% increase in case detection of multi-drug resistant TB (MDR-TB) in 2013, much of which is attributed to the roll out of the UNITAID-funded EXPAND-TB and TBXpert projects.
Cepheid, FIND & Rutgers announce collaboration for next-generation innovations to game-changing Xpert MTB/RIF test (post with simple image)
Xpert MTB/RIF Ultra, the next-generation test for Mycobacterium tuberculosis, will be with increased sensitivity to aid in detection of patients with smear-negative TB, which is often associated with HIV co-infection.
New WHO publication: Xpert MTB/RIF implementation manual (post with simple image)
Technical and operational ‘how-to’: practical considerations
Page 28 of 32 · Total posts: 0←First 27 28 29 Last→